Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Jun. 30, 2017	Jun. 30, 2016
Current assets:
Cash and cash equivalents	$ 3,513,000	$ 3,623,000	$ 5,835,000
Accounts receivable, net of allowance for doubtful accounts of $274,000 ($102,000 and $49,000 at June 30, 2017 and 2016)	1,687,000	3,393,000	3,169,000
Accounts receivable – related party	862,000	308,000
Inventories, net of reserves of $1,069,000 ($1,230,000 and $1,437,000 at June 30, 2017 and 2016)	4,798,000	3,617,000	3,593,000
Prepaid expenses and other current assets	594,000	237,000	246,000
Total current assets	11,454,000	11,178,000	12,843,000
Restricted cash	1,000,000	0	0
Equipment, net	2,996,000	2,330,000	2,962,000
Goodwill	13,976,000	13,195,000	13,195,000
Intangible assets, net	21,629,000	20,165,000	20,821,000
Other assets	56,000	64,000	78,000
Total assets	51,111,000	46,932,000	49,899,000
Current liabilities:
Accounts payable	2,079,000	1,601,000	2,648,000
Accrued payroll and related expenses	532,000	385,000	449,000
Deferred revenue	384,000	597,000	783,000
Related party payable	606,000	606,000
Other current liabilities	1,863,000	1,331,000	1,662,000
Total current liabilities	5,464,000	4,520,000	5,542,000
Long term debt-related party	6,700,000	3,500,000
Derivative obligations	597,000	730,000	670,000
Convertible debentures, net			2,489,000
Noncurrent deferred tax liability	4,730,000	6,968,000	7,641,000
Other noncurrent liabilities	408,000	377,000	1,284,000
Total liabilities	17,899,000	16,095,000	17,626,000
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value; 2,000,000 shares authorized, none issued and outstanding at December 31, 2017 and June 30, 2017 and 2016
Common stock, $0.001 par value; 350,000,000 shares authorized; 10,872,428 issued and outstanding (9,915,868 and 3,010,687 at June 30, 2017 and 2016)	11,000	10,000	3,000
Paid in capital in excess of par	221,371,000	216,222,000	188,569,000
Accumulated deficit	(187,640,000)	(185,357,000)	(156,262,000)
Accumulated other comprehensive loss	(43,000)	(38,000)	(37,000)
Total Cesca Therapeutics Inc. stockholders’ equity	33,699,000	30,837,000	32,273,000
Noncontrolling interests	(487,000)
Total equity	33,212,000	30,837,000	32,273,000
Total liabilities and stockholders’ equity	$ 51,111,000	$ 46,932,000	$ 49,899,000

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.